Crofelemer (USAN, trade name Fulyzaq) is a drug under development for the treatment of diarrhea associated with anti-HIV drugs such as nucleoside analog reverse transcriptase inhibitors and protease inhibitors.
Oligomeric proanthocyanidins, another kind of chemical contained in the latex, are being developed for the treatment of HIV-associated diarrhea under the name crofelemer.